Characterization of a Cryptosporidium muris infection and reinfection in CF-1 mice

Veterinary Parasitology

Volumn 144, Issue 3-4, 2007, Pages 208-221

  Miller, Thomas A ^a   Schaefer III, Frank W ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

B lymphocytes; CD4; CD8; Cryptosporidium muris; Leukocytes; Reinfection; Spleen; T lymphocytes; Thymus

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; GLUCOCORTICOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CRYPTOSPORIDIUM MURIS; FEMALE; FLOW CYTOMETRY; IMMUNOSUPPRESSIVE TREATMENT; INOCULATION; LEUKOCYTE DIFFERENTIAL COUNT; LEUKOCYTE STRUCTURE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; OOCYST; PROTOZOAL INFECTION; SPLEEN; SPLEEN SIZE; T LYMPHOCYTE; THYMUS;

ANIMALS; B-LYMPHOCYTES; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; FECES; FEMALE; GASTROINTESTINAL TRANSIT; MICE; NEUTROPHILS; OOCYSTS; RODENT DISEASES; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND; TIME FACTORS;

CRYPTOSPORIDIUM MURIS; MUS;

EID: 33847062457     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2006.10.026     Document Type: Article

References (33)

1. Abbas A.K., and Lichtman A.H. Cellular and Molecular Immunology (2003), W.B. Saunders Co., Philadelphia pp. 81-103
2. Arrowood M.J., and Donaldson K. Improved purification methods for calf-derived Cryptosporidium parvum oocysts using discontinuous sucrose and cesium chloride gradients. J. Eukaryot. Microbiol. 43 (1996) 89S
3. Ash L.R., and Orihel T.C. Parasites: A Guide to Laboratory Procedures and Identification (1987), American Society of Clinical Pathologists Press, Chicago pp. 33-34
4. Campbell L.D., Stewart J.N., and Mead J.R. Susceptibility to Cryptosporidium parvum infections in cytokine- and chemokine-receptor knockout mice. J. Parasitol. 88 (2002) 1014-1016
5. Cheng L., Rasmussen K.R., Healey M.C., and Yang S. Primary and secondary infections with Cryptosporidium parvum in immunosuppressed adult mice. Am. J. Trop. Med. Hyg. 55 (1996) 324-329
6. Cicmanec J.L., and Reasoner D.J. Enhanced production of Cryptosporidium parvum oocysts in immunosuppressed mice. In: Fricker C.R., Clancy J.L., and Rochelle P.A. (Eds). Proceedings of the 1997 International Symposium on Waterborne Cryptosporidium (1997), American Waterworks Association, Denver 127-131
7. Cifone M.G., Migliorati G., Parroni R., Marchetti C., Millimaggi D., Santoni A., and Riccardi C. Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93 (1999) 2282-2296
8. Enriquez F.J., and Sterling C.R. Cryptosporidium infections in inbred strains of mice. J. Protozool. 38 (1991) 100S-102S
9. Fayer R., and Ungar B.L. Cryptosporidium spp. and cryptosporidiosis. Microbiol. Rev. 50 (1986) 458-483
10. Gatei W., Ashford R.W., Beeching N.J., Kamwati S.K., Greensill J., and Hart C.A. Cryptosporidium muris infection in an HIV-infected adult, Kenya. Emerg. Infect. Dis. 8 (2002) 204-206
11. Goodgame R., Stager C., Marcantel B., Alcocer E., and Segura A.M. Intensity of infection in AIDS-related intestinal microsporidiosis. J. Infect. Dis. 180 (1999) 929-932
12. Holley Jr. H.P., and Thiers B.H. Cryptosporidiosis in a patient receiving immunosuppressive therapy. Possible activation of latent infection. Dig. Dis. Sci. 31 (1986) 1004-1007
13. Huang K., Akiyoshi D.E., Feng X.C., and Tzipori S. Development of patent infection in immunosuppressed C57BL/6 mice with a single Cryptosporidium meleagridis oocyst. J. Parasitol. 89 (2003) 620-622
14. Hurkova L., Hajdusek O., and Modry D. Natural infection of Cryptosporidium muris (Apicomplexa: Cryptosporiidae) in Siberian chipmunks. J. Wildlife Dis. 39 (2003) 441-444
15. Iseki M., Maekawa T., Moriya K., Uni S., and Takada S. Infectivity of Cryptosporidium muris (strain RN 66) in various laboratory animals. Parasitol. Res. 75 (1989) 218-222
16. Mackenzie W.R., Schell W.L., Blair K.A., Addiss D.G., Peterson D.E., Hoxie N.J., Kazmierczak J.J., and Davis J.P. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin. Infect. Dis. 21 (1995) 57-62
17. McDonald V., Deer R., Uni S., Iseki M., and Bancroft G.J. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infect. Immun. 60 (1992) 3325-3331
18. McDonald V., Robinson H.A., Kelly J.P., and Bancroft G.J. Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes. Infect. Immun. 64 (1996) 2556-2562
19. Mead J.R., Arrowood M.J., Healey M.C., and Sidwell R.W. Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. J. Protozool. 38 (1991) 59S-61S
20. Miller T.A., and Schaefer III F.W. Characterization of a single dose methylprednisolone acetate immune suppression model using Cryptosporidium muris and Cryptosporidium parvum. Vet. Parasitol. 141 1/2 (2006) 66-83
21. Miller T.A., Ware M.W., Wymer L.J., and Schaefer III F.W. Chemically and genetically immunocompromised mice are not more susceptible than immunocompetent mice to infection with Cryptosporidium muris. Vet. Parasitol. 143 (2007) 99-105
22. Navin T.R., Weber R., Vugia D.J., Rimland D., Roberts J.M., Addiss D.G., Visvesvara G.S., Wahlquist S.P., Hogan S.E., Gallagher L.E., Juranek D.D., Schwartz D.A., Wilcox C.M., Stewart J.M., Thompson III S.E., and Bryan R.T. Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20 (1999) 154-159
23. Novak S.M., and Sterling C.R. Susceptibility dynamics in neonatal BALB/c mice infected with Cryptosporidium parvum. J. Protozool. 38 (1991) 103S-104S
24. O'Donoghue P.J. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol. 25 (1995) 139-195
25. Ozkul I.A., and Aydin Y. Natural Cryptosporidium muris infection of the stomach in laboratory mice. Vet. Parasitol. 55 (1994) 129-132
26. Rasmussen K.R., and Healey M.C. Experimental Cryptosporidium parvum infections in immunosuppressed adult mice. Infect. Immun. 60 (1992) 1648-1652
27. Scaglia M., Bruno A., Chichino G., Atzori C., Cevini C., and Gatti S. Cryptosporidium parvum life cycle in suckling mice: a Nomarski interference-contrast study of a human-derived strain. J. Protozool. 38 (1991) 118S-121S
28. Schalm O.W. Veterinary Hematology (1970), Lea and Febiger, Philadelphia, PA pp. 440-447
29. Schito M.L., Chobotar B., and Barta J.R. Cellular dynamics and cytokine responses in BALB/c mice infected with Eimeria papillata during primary and secondary infections. J. Parasitol. 84 (1998) 328-337
30. Shimizu M.S., Yamada S., Kawashima K., Ohashi S., Shimizu S., and Ogawa T. Changes of lymphocyte subpopulations in pigs infected with porcine reproductive and respiratory syndrome (PRRS) virus. Vet. Immunol. Immunopath. 50 (1996) 19-27
31. Taylor M.A., Marshall R.N., Green J.A., and Catchpole J. The pathogenesis of experimental infections of Cryptosporidium muris (strain RN 66) in outbred nude mice. Vet. Parasitol. 86 (1999) 41-48
32. Tzipori S., and Griffiths J.K. Natural history and biology of Cryptosporidium parvum. In: Tzipori S. (Ed). Advances in Parisitology-opportunistic Protozoa in Humans, vol. 40 (1998), Academic Press, London 5-36
33. Xiao L., Fayer R., Ryan U., and Upton S.J. Cryptosporidium taxonomy: recent advances and implications for public health. Clin. Microbiol. Rev. 17 (2004) 72-97